Back
Aytu BioPharma Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
20
AYTU
Aytu BioPharma
Last Price:
1.61
Seasonality Move:
23.23%
Buy
60
BMY
Bristol-Myers Squibb
Last Price:
58.91
Seasonality Move:
2.73%
Sell
20
Aytu BioPharma (AYTU)
is a Sell
Is Aytu BioPharma a Buy, Sell or Hold?
- The current Aytu BioPharma [AYTU] share price is $1.63. The Score for AYTU is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- AYTU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $58.87. The Score for BMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AYTU Stock Price Chart
What is Aytu BioPharma's stock price today?
-
The Aytu BioPharma share price today is $1.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AYTU is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $58.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AYTU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | 27366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.61 - 2.07) | Sell |
| Bollinger Bands (100): | (2 - 2.72) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 62.59 | Buy |
| Chaikin Money Flow: | 6856912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.03 - 58.03) | Buy |
| Bollinger Bands (100): | (45.2 - 54.78) | Buy |
AYTU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Buy |
| 20-day SMA: | 1.76 | Sell |
| 50-day SMA: | 2.12 | Sell |
| 200-day SMA: | 2.68 | Sell |
| 8-day EMA: | 1.6 | Buy |
| 20-day EMA: | 1.75 | Sell |
| 50-day EMA: | 2.03 | Sell |
| 200-day EMA: | 2.56 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.89 | Buy |
| 20-day SMA: | 56.27 | Buy |
| 50-day SMA: | 53.58 | Buy |
| 200-day SMA: | 48.51 | Buy |
| 8-day EMA: | 57.86 | Buy |
| 20-day EMA: | 56.51 | Buy |
| 50-day EMA: | 53.96 | Buy |
| 200-day EMA: | 50.8 | Buy |
Aytu BioPharma Earnings Growth & AYTU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.44 per share, and a decrease next year of $0.00 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.49 per share, and an increase next year of $6.16 per share.
Aytu BioPharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||